CCOP - St. Francis Hospital/Natalie Warren Bryant Cancer Center

Tulsa, Oklahoma 74136

0 studies enrolling now · 13 studies all time

What they study most

Bladder Cancer, Breast Cancer, Esophageal Cancer, Fallopian Tube Cancer, Gastric Cancer, Leukemia, Lung Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Sarcoma, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer

Studies at this site

• Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract — Completed
• Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia — Completed
• Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach — Completed
• Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Stopped early
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Stopped early
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer — Stopped early
• Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer — Completed
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer — Completed
• Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer — Completed
• Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy — Completed
• Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer — Stopped early
• Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer — Stopped early
• Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer — Completed